Good News! AstraZeneca’s antibody cocktail can treat COVID-19
London: AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released ...
Read moreDetailsLondon: AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released ...
Read moreDetailsWashington: Drugmaker Merck asked Monday US Regulators to authorise its pill against Covid-19. Merck has said that the pill would ...
Read moreDetailsCanberra: The Australian government has outlined plans to lift a pandemic ban on its vaccinated citizens travelling overseas from November. ...
Read moreDetailsLondon: UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat ...
Read moreDetailsLondon: The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's ...
Read moreDetailsBrussels: The European Union says it's reached an agreement with drugmaker AstraZeneca to end their legal battle over the slow ...
Read moreDetailsNew York: Drugmakers Pfizer, BioNTech and Moderna are expected to reap billions of dollars from Covid-19 booster shots in a ...
Read moreDetailsLondon: The incidence of rare blood clot is higher following a Covid-19 infection than two doses of AstraZeneca or Pfizer/BioNTech ...
Read moreDetailsLondon: Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines. Then the antibodies ...
Read moreDetailsBhubaneswar: Foreign-bound Indian nationals, who have taken the first dose of Covishield or AstraZeneca vaccine in a foreign country, can ...
Read moreDetails